Wright Medical Group News

's stock had its "neutral" rating restated by Zacks in a report issued on Monday.

Gliatech Inc. is principally engaged in the discovery and development of biosurgery and pharmaceutical products.

Wright Medical Group Inc., a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, reported financial results for its first quarter ended March 31, 2012.

's stock had its "hold" rating reaffirmed by research analysts at Wunderlich in a report released on Wednesday.

The firm currently has a "hold" rating on the stock. The analysts wrote, "Wright is still in the very early stages of its plan to accelerate revenue growth and improve cash flows.

ARLINGTON, Tenn. -- -- Wright Medical Group, Inc. , a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its first quarter ended March 31, 2012.

Wednesday, May. 2, 2012 Tuesday, May. 1, 2012 Monday, Apr. 30, 2012 Friday, Apr.